Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
In premarket trading, SMMT rose on a reported $2 billion AstraZeneca investment. IOVA gained after raising full-year 2026 revenue guidance to $410–$420 million. Other gainers included FCEL (+9.5% on initiating OUTPERFORM), NVTS (U.S. government selection to develop next-generation 10 kV SiC power semiconductors), UEC (
Premarket gainers highlighted include SMMT (+17%), NVTS (+10%), KMX (+8%), FCEL (+7%), PLUG (+6%), IOVA (+5.5%), BFLY (+4%) and UEC (+3.5%). Mentioned catalysts include AstraZeneca’s reported investment, a U.S. government selection of Navitas for next-generation 10 kV SiC power semiconductors development, earnings and